ReOx Ltd engages in research and development of drugs for treatments of disease by controlling the activity of hypoxia inducible factor.
ReOx Ltd engages in research and development of drugs for treatments of disease by controlling the activity of hypoxia inducible factor.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 30, 2003 | Seed | £2M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
University Challenge Fund | — | Seed |